share_log

Tonix Pharmaceuticals Says It Is Developing A Vaccine Candidate Called TNX-801 As WHO Declared MPOX A Public Health Emergency Of International Concern On Aug. 14

Benzinga ·  Aug 23 07:55

Tonix has successfully completed non-human primate studies showing protection from challenge with lethal doses of the Clade 1 monkeypox virus that is driving the new epidemic.

Clearly more testing is ahead for TNX-801, but the technology behind it is rooted in the science of Edward Jenner's smallpox vaccine of the late 1700s, the only vaccine to successfully eradicate a contagious viral pathogen.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment